 Leilah Zahedi-Spung
Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abortion, Induced | 4 | 2023 | 71 | 2.330 |
Why?
| | Infectious Disease Transmission, Vertical | 2 | 2018 | 150 | 1.090 |
Why?
| | Umbilical Arteries | 2 | 2022 | 41 | 0.970 |
Why?
| | Abortion, Spontaneous | 1 | 2023 | 89 | 0.840 |
Why?
| | Blood Gas Analysis | 2 | 2022 | 70 | 0.830 |
Why?
| | Nuchal Cord | 1 | 2022 | 3 | 0.800 |
Why?
| | Pregnancy | 11 | 2023 | 5499 | 0.790 |
Why?
| | Obstetric Labor, Premature | 1 | 2021 | 33 | 0.750 |
Why?
| | Vasa Previa | 1 | 2021 | 2 | 0.750 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2021 | 34 | 0.750 |
Why?
| | Infant, Extremely Premature | 1 | 2021 | 57 | 0.720 |
Why?
| | Infant, Premature, Diseases | 1 | 2021 | 88 | 0.690 |
Why?
| | Premature Birth | 1 | 2021 | 275 | 0.580 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2018 | 285 | 0.580 |
Why?
| | Anti-Retroviral Agents | 1 | 2018 | 207 | 0.540 |
Why?
| | Primary Prevention | 1 | 2018 | 172 | 0.530 |
Why?
| | Prenatal Care | 1 | 2018 | 250 | 0.500 |
Why?
| | Gestational Age | 3 | 2023 | 761 | 0.490 |
Why?
| | Infant, Newborn | 6 | 2022 | 5038 | 0.460 |
Why?
| | HIV Infections | 2 | 2018 | 2453 | 0.460 |
Why?
| | Medication Adherence | 1 | 2018 | 531 | 0.450 |
Why?
| | Missouri | 2 | 2022 | 61 | 0.390 |
Why?
| | Physicians | 1 | 2020 | 765 | 0.390 |
Why?
| | Anti-HIV Agents | 1 | 2018 | 663 | 0.390 |
Why?
| | Perinatology | 2 | 2021 | 6 | 0.360 |
Why?
| | Carbon Dioxide | 2 | 2022 | 218 | 0.360 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2087 | 0.310 |
Why?
| | Female | 11 | 2023 | 59325 | 0.290 |
Why?
| | Retrospective Studies | 4 | 2022 | 12521 | 0.250 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2022 | 507 | 0.220 |
Why?
| | Fetal Blood | 2 | 2022 | 268 | 0.220 |
Why?
| | Ethics, Business | 1 | 2023 | 1 | 0.220 |
Why?
| | Organizations | 1 | 2023 | 19 | 0.210 |
Why?
| | Texas | 1 | 2023 | 188 | 0.210 |
Why?
| | Acidosis, Respiratory | 1 | 2022 | 3 | 0.210 |
Why?
| | Social Responsibility | 1 | 2023 | 45 | 0.210 |
Why?
| | Humans | 12 | 2023 | 114043 | 0.200 |
Why?
| | Pregnant Women | 1 | 2023 | 129 | 0.200 |
Why?
| | Term Birth | 1 | 2022 | 19 | 0.200 |
Why?
| | Tertiary Care Centers | 1 | 2022 | 126 | 0.190 |
Why?
| | Multivariate Analysis | 2 | 2022 | 1422 | 0.190 |
Why?
| | ROC Curve | 1 | 2022 | 441 | 0.190 |
Why?
| | Parity | 1 | 2021 | 97 | 0.180 |
Why?
| | Infant Mortality | 1 | 2021 | 91 | 0.180 |
Why?
| | Umbilical Cord | 1 | 2021 | 80 | 0.180 |
Why?
| | Infant, Small for Gestational Age | 1 | 2021 | 75 | 0.180 |
Why?
| | Abortion, Criminal | 1 | 2020 | 1 | 0.180 |
Why?
| | Logistic Models | 2 | 2022 | 1829 | 0.180 |
Why?
| | Residence Characteristics | 1 | 2022 | 274 | 0.170 |
Why?
| | Cesarean Section | 1 | 2021 | 169 | 0.170 |
Why?
| | Infant | 2 | 2022 | 7943 | 0.160 |
Why?
| | Hospitals | 1 | 2023 | 581 | 0.160 |
Why?
| | Pregnancy Outcome | 1 | 2021 | 337 | 0.160 |
Why?
| | Georgia | 1 | 2018 | 62 | 0.160 |
Why?
| | Women's Health | 1 | 2020 | 270 | 0.150 |
Why?
| | HIV | 1 | 2018 | 208 | 0.140 |
Why?
| | United States | 4 | 2023 | 12137 | 0.140 |
Why?
| | Viral Load | 1 | 2018 | 405 | 0.140 |
Why?
| | Adult | 4 | 2022 | 30375 | 0.140 |
Why?
| | Health Services Accessibility | 1 | 2022 | 756 | 0.130 |
Why?
| | Postpartum Period | 1 | 2018 | 275 | 0.130 |
Why?
| | Program Development | 1 | 2018 | 339 | 0.130 |
Why?
| | Placenta | 1 | 2021 | 628 | 0.120 |
Why?
| | Young Adult | 2 | 2022 | 10444 | 0.120 |
Why?
| | Electronic Health Records | 1 | 2021 | 799 | 0.120 |
Why?
| | Prospective Studies | 2 | 2022 | 6195 | 0.110 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 970 | 0.110 |
Why?
| | Program Evaluation | 1 | 2018 | 820 | 0.110 |
Why?
| | Cohort Studies | 1 | 2021 | 4883 | 0.100 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 4595 | 0.090 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4402 | 0.080 |
Why?
| | Male | 4 | 2022 | 55396 | 0.070 |
Why?
| | Risk Factors | 1 | 2018 | 8614 | 0.060 |
Why?
| | Supreme Court Decisions | 1 | 2023 | 10 | 0.050 |
Why?
| | Partial Pressure | 1 | 2022 | 30 | 0.050 |
Why?
| | Hypercapnia | 1 | 2022 | 50 | 0.050 |
Why?
| | Area Under Curve | 1 | 2022 | 273 | 0.050 |
Why?
| | Reproductive Health Services | 1 | 2021 | 10 | 0.050 |
Why?
| | Adolescent | 1 | 2018 | 17800 | 0.040 |
Why?
| | Family Planning Services | 1 | 2021 | 68 | 0.040 |
Why?
| | Societies, Medical | 1 | 2021 | 655 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2021 | 632 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 1 | 2021 | 1175 | 0.030 |
Why?
| | Internship and Residency | 1 | 2021 | 920 | 0.020 |
Why?
|
|
Zahedi-Spung's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|